Monogram Technologies Inc.

MGRM

{{popupValue}}
{{popupSubtitle}}

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker
MGRM
CIK0001769759
SIC3841
SectorManufacturing
Industry CategoryMedical Equipment
Industry GroupSurgical, Medical, And Dental Instruments And Supplies

Contact

Address53 BRIDGE STREET UNIT 507, BROOKLYN, NY, 11201
Website www.monogramorthopedics.com
Phone(718) 576-3205
CEOBenjamin Sexson
EmployeesN/A

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement
RevenueN/A
Pre-Tax Income$-16.01 million
Net Income$-16.01 million
Net Income to Common$-16.36 million
EPS$-0.50
View All
Balance Sheet
Cash$13.27 million
Assets$15.36 million
Liabilities$3.67 million
Common Equity$11.68 million
Liabilities & Equity$15.36 million
View All
Cash Flow Statement
Calculations
NOPAT$-10.52 million
EBITDA$-14.60 million
Price to EarningsN/A
Price to Book$16.46
ROE-146.09%
View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

Monogram robot marks autonomy milestone; Stereotaxis catheter cleared

Monogram Technologies conducted its first fully autonomous robotic knee replacement surgery, while Stereotaxis won FDA clearance for a robotically navigated electrophysiology mapping catheter.

Article Link

Monogram completes fully autonomous saw-based robotic knee replacement procedure

Monogram Technologies announced that on Saturday, July 26, Monogram completed a fully autonomous saw-based robotic knee replacement procedure on a live patient. The procedure was performed at the Krishna Shalby Hospital in Ahmedabad India, as part of Monogram’s multi-center clinical trial in India for the Monogram TKA System. As previously announced, Monogram and Shalby partnered to evaluate the safety and effectiveness of the mBos TKA System with the Consensus CKS implant, which is substantiall

Article Link

Monogram Technologies Announces World’s First Fully Autonomous Saw-Based Robotic Knee Replacement Surgery

The Procedure Utilized Monogram’s mBôs TKA System Performed in India with Shalby Hospitals Groundbreaking Procedure Delivers the World’s First Autonomous Saw-Based Robotic TKA Surgery on a Live Patient AUSTIN, Texas, July 29, 2025 (GLOBE NEWSWIRE) -- Monogram Technologies Inc. (NASDAQ: MGRM) ("Monogram" or the "Company"), an AI-driven robotics company revolutionizing orthopedic surgery, today announced that on Saturday, July 26, 2025, Monogram completed the first ever fully autonomous saw-based

Article Link

MGRM: Monogram Technologies to be Acquired by Large Medical Device Company Zimmer Biomet Holdings

By Thomas Kerr, CFA NASDAQ:MGRM | NYSE:ZBH READ THE FULL MGRM RESEARCH REPORT On July 14, 2025, Monogram (NASDAQ:MGRM) announced they were being acquired by leading medical device company Zimmer Biomet (NYSE:ZBH). The following press release was issued in conjunction with the announcement: WARSAW, Indiana and AUSTIN, Texas, July 14, 2025 (GLOBE NEWSWIRE) - Zimmer Biomet Holdings, Inc. (NYSE and

Article Link

DoorDash, Southwest downgraded: Wall Street's top analyst calls

DoorDash, Southwest downgraded: Wall Street's top analyst calls

Article Link